Phase 1b/2a study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) combined with low-dose nivolumab (LDN) in virally-suppressed patients with CHB on nucleos (t)ide analogues
T. M. Evans, Eleanor Barnes
Topics & Concepts
HeterologousMedicineVirologyNivolumabVaccinationHepatitis B virusPhase (matter)ImmunologyVirusBiologyPhysicsImmunotherapyGeneImmune systemGeneticsQuantum mechanicsHepatitis B Virus StudiesCancer Immunotherapy and BiomarkersPolyomavirus and related diseases